Atlas Trials

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

Clinical trial NCT00631163 · COMPLETED

Trial details

NCT number
NCT00631163
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic AnemiaTransfusional Hemosiderosis
Start date
2007-10-01
Primary completion
2011-01-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.